secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2025-12-05T23:59:59+00:00
Accession:  0001567264-25-000111
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics receives Nasdaq extension until June 1, 2026 to meet $1 bid price rule
--------------------------------------------------------------------------------

- Received 180-day extension from Nasdaq to June 1, 2026 to regain compliance with $1.00 minimum bid price rule.
- Initial compliance period ended Dec 3, 2025; company previously notified of deficiency on June 6, 2025.
- To regain compliance, closing bid price must be at least $1.00 for ten consecutive business days before June 1, 2026.
- Company considering reverse stock split if needed; trading symbol INTS continues on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000111/0001567264-25-000111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000111/intensity-20251204.htm
  HTML page:      https://secwatch.observer/filing/0001567264-25-000111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer